Thursday, November 18, 2010
Print Current Session:
![]() |
|
Thursday
SESSION XIX:
CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2010 (5-MINUTE TALKS)
Moderators:Thomas S. Riles, MD / Anne L. Abbott, MD, PhD, FRACP
|
|
SESSION XIX SCHEDULE | |
2:22 PM - 2:27 PM | Ten Top Tips For SAFE CAS: A Neuroradiologist’s Perspective |
Presenters(s):Emmanuel M. Houdart, MD | |
2:28 PM - 2:33 PM | Debate 8: CREST Has Restored CAS To Its Rightful Place As Best Treatment For Most Carotid Stenoses: An Interventionalist’s Perspective |
Presenters(s):William A. Gray, MD | |
2:34 PM - 2:39 PM | Debate 8: CREST May Be Helpful To Advocates Of CAS But It Is Not The Final Answer: When CEA, When CAS, When Best Medical Treatment (BMRx): A Surgeon’s Perspective |
Presenters(s):Wesley S. Moore, MD | |
2:40 PM - 2:45 PM | Debate 8: Subanalysis Of CREST Results Are Important: Were There Differences Between CAS And CEA In 1) Quality Of Life And 2) Cost Effectiveness; What Were The Severity And Disability From The MIs And The Cranial Nerve Injuries: A Neurologist’s Perspective |
Presenters(s):Thomas G. Brott, MD | |
2:46 PM - 2:51 PM | The Woes Of CAS Are Not Fully Solved By CREST: When Is CAS Justified And When And Why Is It Not? |
Presenters(s):Frank J. Criado, MD, FACS, FSVM | |
2:52 PM - 2:57 PM | Debate 9: We Do Not Need Any More CAS Trials After CREST And ICSS |
Presenters(s):Mark H. Wholey, MD | |
2:58 PM - 3:03 PM | Debate 9: We Need Additional CAS Trials And Why |
Presenters(s):Andrew N. Nicolaides, MS, FRCS | |
3:04 PM - 3:09 PM | Debate 10: Asymptomatic Carotid Stenosis Is Still An Indication For Treatment By CEA Or CAS In Most Patients Needing Aggressive Treatment (CABG Or PCI) For Coronary Artery Disease |
Presenters(s):John (Jeb) W. Hallett, MD | |
3:10 PM - 3:15 PM | Debate 10: Asymptomatic Carotid Stenosis Is Still An Indication For CEA Or CAS, In Some Patients Needing Aggressive Treatment (CABG Or PCI) For Coronary Artery Disease |
Presenters(s):John J. Ricotta, MD | |
3:16 PM - 3:21 PM | Debate 10: Most Patients Undergoing Cardiac Surgery With Asymptomatic Carotid Disease Do Not Benefit From A Synchronous Or Staged Carotid Intervention |
Presenters(s):A. Ross Naylor, MD, FRCS | |
3:22 PM - 3:27 PM | Panel Discussion |
Moderator(s): Frank J. Veith, MD / Mark H. Wholey, MD | |
3:27 PM - 3:32 PM | Are There Neuropsychological Complications Of CAS Or CEA In The Absence Of Strokes? |
Presenters(s):Wei Zhou, MD | |
3:33 PM - 3:38 PM | CAS vs. CEA: What Are The DWI MRA, Brain Damage Markers And Neuropsychological Consequences Of The Two Procedures In Asymptomatic Patients: An Update |
Presenters(s):Laura Capoccia, MD | |
3:39 PM - 3:44 PM | SPACE II: The Most Needed Comparison Of CAS, CEA And BMRx For Asymptomatic Disease: Will It Provide Answers And When? |
Presenters(s):Hans-Henning Eckstein, MD, PhD | |
3:45 PM - 3:50 PM | When Is Cessation Or Reversal Of Brain Flow Protection A Must In CAS: What Are Its Disadvantages? |
Presenters(s):L. Nelson Hopkins, MD | |
3:51 PM - 3:56 PM | National Database Update On CEA vs. CAS For Symptomatic And Asymptomatic Disease: Are CAS Results Improving? |
Presenters(s):Mohammad H. Eslami, MD, RVT | |
3:57 PM - 4:02 PM | Serial Duplex Measurements Of Asymptomatic Carotid Lesions: Will They Help Identify Patients At Higher Risk For Stroke Who Will Benefit More From Invasive Treatment? |
Presenters(s):Alison Halliday, MS, FRCS | |
4:03 PM - 4:08 PM | How Can Asymptomatic Patients With Carotid Stenoses Be Identified To Be At High Stroke Risk In The Statin Era? |
Presenters(s):J. David Spence, MD | |
4:09 PM - 4:15 PM | Panel Discussion |
4:15 PM - 4:25 PM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 19.1 - Toward Safer CAS: Tips And Tricks |
Presenters(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
Web-Based Presentation | 19.2 - Does The CRYSTALLO Variable Cell Size Stent Lower Embolic Event Rates With CAS? |
Presenters(s):Alberto Cremonesi, MD, FESC | |
Web-Based Presentation | 19.3 - Right Brachial Approach For Left Carotid Stenting With A Bovine Arch Anatomy |
Presenters(s):Patrick E. Muck, MD, RVT, FACS | |
Web-Based Presentation | 19.4 - Radial Approach For CAS: When, Why And How |
Presenters(s):Ali Amin, MD, RVT, FACS, FACC | |
Web-Based Presentation | 19.5 - Flaws In The Empire Trial |
Presenters(s):Michael H. Wholey, MD, MBA | |
Web-Based Presentation | 19.6 - Will The TACIT Trial Ever Be Done? |
Presenters(s):Barry T. Katzen, MD | |
END OF SESSION XIX | |
previous | next |